Skip to main content
Category

News Archive

business-of-biotech-logo

SBIR Reauthorization Moves Forward | BIOtechNow

By News Archive

business-of-biotech-logo

NIH has reissued its Small Business Innovation Research (SBIR) Omnibus Grant Solicitation announcement, which states that small businesses that are majority-owned by multiple venture capital operating companies are eligible to apply for (1) these SBIR grants and (2) any other NIH SBIR funding opportunities announced after January 28, 2013.  The NIH grant solicitation announcement can be found here.

With this re-issuance, small businesses that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are now eligibleto apply to the NIH SBIR program and compete for up to 25% of NIH’s SBIR set-aside.

Read More
telelight-sxc

Telehealth sees explosive growth | Healthcare IT News

By News Archive

telelight-sxc

Healthcare providers are taking telemedicine to new heights, with the market seeing growth of a whopping 237 percent within a five-year period, according to a new Kalorama report.

Officials say the telemedicine patient monitoring market grew from $4.2 billion in 2007 to more than $10 billion in 2012. According to the report, the market itself is considered small- to moderate in size but makes up for it with its notable number of competitors and “increasing awareness of effectiveness.”

Read More
google-ventures-logo

Google Ventures partner: Bring on the pitches for HIT and Google Glass for healthcare | MedCity News

By News Archive

google-ventures-logo

More than 60 companies showed off their health data applications at Datapalooza IV this week and Krishna Yeshwant, a partner at Google Ventures, was the MC for a demo session on Tuesday afternoon.

As one of the presenters was fighting with his PowerPoint demonstration and the projection system, Yeshwant answered a few questions about opportunities for healthcare startups with the search company’s investment group. He said that the outlook has changed for healthcare IT startups now that Obamacare is here to stay.

Read More
liftlab-medcity

Rock Health version 5 features Google Glass for doctors, tremor cancelation technology | MedCity News

By News Archive

liftlab-medcity

San Francisco digital health accelerator Rock Health is kicking off its fifth program next week, and it has some unique startups in the mix.

Bound to be the most talked about is Augmedix, which is developing a healthcare app for Google Glass. Co-founders Ian Shakil and Pelu Tran haven’t said much about exactly what kind of app they’re working on, but it apparently will leverage Glass’s augmented reality and voice activation to help doctors keep their focus on patients. Augmedix has already raised $55,000 from 32 Upstart backers.

Read More
chinese-biopharma

18th CBA Annual Conference | Chinese Biopharmaceutical Association, USA

By News Archive

chinese-biopharma

The Chinese Biopharmaceutical Association, USA (CBA) will host the 18th Annual Conference at the University of Maryland Shady Grove Conference Center on Saturday, June 15th, 2013. The theme of this year’s conference is “Global Partnership in Biopharmaceutics and Translational Medicine;” it will address the critical importance of establishing worldwide collaboration to capture the great opportunity for the advancement of modern medicine and biopharmaceuticals.  

The Conference

The Conference includes five sessions:  

  • Drug Discovery: New Strategies and Platforms
  • Translational Genomics and anti-cancer therapy
  • Opportunities in New high tech parks in China
  • Regulatory Compliances in Biopharmaceuticals
  • Collaborative Opportunities and Partnership for U.S.-China Biopharmaceuticals.
Read More
eight-minutes-doctors-care2

You’ve Only Got 8 Minutes With the Doctor So Talk Fast | Care2 Causes

By News Archive

eight-minutes-doctors-care2

Eight minutes: this is approximately (1) how long it takes sunlight to reach the earth; (2) how long it takes to hard-boil an egg (if you eat them) and (3) how long medical residents — doctors in training — spend with patients per day on average.

What’s more, researchers from Johns Hopkins University and the University of Maryland have found that those eight minute are less than the amount of time that residents used to spend with patients (and make the standard 15 minutes allotted to a medical office visit seem generous).

Read More
modern-intern-bostonglobe

Computers vs. patients: A day in the life of a modern intern – Health & wellness – The Boston Globe

By News Archive

modern-intern-bostonglobe

If you’re a medical intern, most of what you need to do your job can be pulled off a computer screen: Blood test results. Paged messages. Orders to start a medication. All but, of course, how sick a patient is.

Researchers at Johns Hopkins University and the University of Maryland, suspecting that more and more of an intern’s time is spent in front of a computer, looked into just how today’s intern spends her working hours on an inpatient ward. They asked trained college students to shadow 29 internal medicine interns from two different Baltimore teaching hospitals and document how much time they spent talking to patients, eating lunch, reading charts, and the like — over the course of three weeks. Their recently published results confirm a trend that old-timers nostalgically lament and that those of us in training know to be all too true: Only a small percentage of our time is spent in direct patient care.

Read More
NewImage

The Biotech IPO Scorecard: Who’s Up, Who’s Down in 2013 | Xconomy

By News Archive

NewImage

Remember Plexxikon? The Berkeley, CA-based company had a lot of talent for structural biology-based drug design, an impressive new treatment for melanoma, and a strong management team.

Two years ago, nobody on Wall Street cared one whit. Plexxikon flirted with the idea of going public, found little interest, and sold itself off to Japan-based Daiichi Sankyo for a more than 10-fold return on investment. It was a poster child for how dead the biotech IPO market was in 2010 and 2011.

Read More
qiagen-logo2

Qiagen Acquires New Cancer Biomarkers Through Licensing Agreements | IVD Technology

By News Archive

qiagen-logo2Through new agreements with the Canadian BC Cancer Agency and Columbia University, the company now has access to biomarkers for lymphoma, glioblastoma, and several other cancers. These biomarkers will be developed into diagnostic assays that can assist physicians in choosing targeted treatments, Qiagen says.

The company’s glioblastoma cancer biomarker, acquired from Columbia University, detects the presence of FGFR-TACC fusion genes. The lymphoma biomarker, acquired from BC Cancer Agency, detects the Y641 EZH2 gene mutation. This type of lymphoma is targeted by pharmaceutical manufacturers like Epizyme and Constellation.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.